AQA
ABMD

Alpha Quant Advisors’s Abiomed Inc ABMD Stock Holding History

Alpha Quant Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$187K Sell
654
-75
-10% -$24.9K 0.19% 118
2018
Q4 		$237K Buy
+729
New +$253K 0.25% 110

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alpha Quant Advisors's ABMD Position: Q1 2019 in Review

Alpha Quant Advisors reduced its Abiomed Inc (ABMD) stake by 10% in Q1 2019, selling an estimated $24.9K and leaving 654 shares worth $187K. The position accounts for 0.19% of the portfolio, ranked #118.

Alpha Quant Advisors first reported a position in ABMD in Q4 2018 and has held it in 2 quarters since. The position peaked at $237K in Q4 2018. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • Alpha Quant Advisors held 654 shares of Abiomed Inc worth $187K as of Q1 2019.
  • Alpha Quant Advisors sold 75 Abiomed Inc shares in Q1 2019, an estimated $24.9K.
  • Abiomed Inc made up 0.19% of Alpha Quant Advisors's portfolio in Q1 2019, its #118 holding.
  • Alpha Quant Advisors first reported a position in Abiomed Inc in Q4 2018 and has held it in 2 quarters since.
  • Alpha Quant Advisors's Abiomed Inc position peaked at $237K in Q4 2018.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.